미국의 의료 BPO : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the united states healthcare bPO market size is expected to grow from USD 154.36 billion in 2025 to USD 165.05 billion in 2026 and is forecast to reach USD 245.46 billion by 2031 at 8.26% CAGR over 2026-2031.

This report is Segmented by Service Type (Payer Service [Claims Management and More], Provider Service [Patient Care Service and More] and More), Delivery Model (Onshore, Nearshore, Offshore), Service Delivery Mode (Captive, Third-Party, Hybrid), and End Customer (Payers, Providers, Pharmaceutical & Biotech, Government Agencies). The Market Forecasts are Provided in Terms of Value (USD).

United States Healthcare BPO Market Trends and Insights

Escalating Administrative-Cost Pressure on Payers & Providers

Hospitals spend USD 19.7 billion each year disputing denied claims, with 2025 denial rates ranging from 11.8% to 19%, pushing CFOs to outsource revenue-cycle tasks to variable-fee partners that can cut fixed labor and improve cash collections. National health expenditure reached USD 4.9 trillion in 2023 and is projected to rise at 5.8% annually through 2033, magnifying workloads related to eligibility verification, prior authorization, and claims adjudication. Commercial reimbursement growth continues to lag medical-cost inflation by 150-200 basis points, squeezing provider margins and making non-clinical outsourcing unavoidable. Nearly half of rural hospitals posted operating losses in 2023-2024, and more than 600 facilities remain at high financial risk, so revenue-cycle BPO is becoming a lifeline for sustaining patient services. Payers face similar pressure as medical loss ratios hover near regulatory ceilings; nine of the 10 largest U.S. health plans already rely on Conduent for claims and member operations.

Advanced Tech Adoption (AI, RPA, Analytics) Unlocking Scale Efficiencies

Generative-AI is collapsing review cycle times and staff hours across prior authorization, appeals, and utilization-management workflows. HCLTech showed that its GenAI solution can cut clinical-review time from three hours to 20 minutes and reduce costs by 30% for a regional Blue Cross plan. A 1-million-member insurer typically spends USD 50-70 million on clinical-review labor and maintains 200-300 nurse FTEs; GenAI-powered extraction and summarization now let nurses validate decisions instead of gathering documents, shrinking staffing needs. Optum Real, rolled out in April 2024, enables instant coverage validation, and early pilots at Allina Health recorded lower administrative errors and better patient experience. Cognizant's BPaaS platform blends RPA and machine learning to deliver 25-50% reductions in total cost of ownership, while EmblemHealth reported a 99% improvement in claims-first-pass yield after deployment. IBM Consulting says biopharma clients now close regulatory documentation cycles 50-75% faster by using generative AI for content-heavy workflows.

Cyber-Security & Data-Privacy Concerns Post-Breach

The Change Healthcare ransomware attack disrupted claims for thousands of providers, exposed nearly 200 million records, and triggered a reassessment of vendor cyber-risk protocols. A 2024 JAMA study counted 566 breaches affecting 170 million records, with ransomware responsible for 69% of compromised data. HHS's Office for Civil Rights issued HIPAA settlements totaling USD 875,000 in 2024 alone, underscoring rising enforcement. Payers now require vendors to hold SOC 2 Type II attestations, independent penetration tests, and high-limit cyber-insurance, raising the cost of entry for small offshore suppliers. Conduent's January 2025 security incident heightened concerns and spotlighted the need for transparent incident-response playbooks. Several states are considering legislation mandating minimum cybersecurity standards for healthcare BPO vendors, which would further favor large providers with mature security operations.

Other drivers and restraints analyzed in the detailed report include:

1. Heightening Regulatory Complexity
2. Surge in BPaaS Adoption by Small & Mid-Size Payers
3. Shrinking Offshore Cost Arbitrage Amid Tariffs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Pharmaceutical Services accounted for 58.62% of United States healthcare BPO market share in 2025, anchored by clinical-trial management, regulatory documentation, and manufacturing quality assurance as sponsors accelerate drug-development timelines. IQVIA logged USD 15.4 billion in 2024 revenue and carried a USD 32 billion backlog, illustrating unrelenting demand for contract-research capacity. FDA guidance on decentralized clinical trials released in September 2024 expands the outsourcing remit to remote monitoring and home-health components, driving new use cases. Provider Services, however, are projected to grow fastest at a 12.73% CAGR between 2026-2031 as hospitals battle denial rates of up to 19% and rising cost-to-collect, pushing them toward full-service revenue-cycle partners. The United States healthcare BPO market size for provider-oriented deals is set to accelerate sharply as health systems seek end-to-end claims, coding, and patient-financial-engagement solutions.

Pharma outsourcing continues to diversify beyond clinical research into supply-chain logistics, batch-record reviews, and omnichannel sales enablement, responding to stricter 21 CFR Part 11 data-integrity enforcement. Manufacturing-support BPO is particularly attractive for small biotech firms that lack validated quality-assurance systems. Conversely, Payer Services remain a stable mid-market niche where entrenched relationships between national insurers and platform-centric vendors constrain churn. Cognizant's TriZetto alone handles billions of transactions for 650 plans, reinforcing stickiness through deep system integration. Overall, the United States healthcare BPO market continues to reward vendors that marry domain expertise with scalable technology rather than pure labor arbitrage.

Offshore Delivery commanded 81.35% of 2025 spending, reflecting two decades of vendor investment in HIPAA-ready centers across India and the Philippines. Yet erosion in labor-cost differentials and tariff-driven hardware inflation are tilting growth toward nearshore locations, where the United States healthcare BPO market size is poised to expand swiftly. Nearshore centers offer same-day time-zone support, lowering hand-off latency between payers, providers, and BPO teams. The February 2024 breach intensified scrutiny of offshore cybersecurity controls, and payers now favor proximity for easier audits and real-time incident response.

Onshore Delivery remains essential for high-complexity clinical services that require licensed nurses and direct provider interaction. Optum blends onshore clinical oversight with offshore transaction processing to balance quality and cost. Offshore majors like Cognizant and Genpact are racing to establish nearshore hubs, yet capital investments in Mexico and Colombia will dampen margins in the short term. Hybrid delivery models that orchestrate onshore oversight, nearshore execution, and offshore bulk processing are becoming the norm, forcing vendors to invest in platform orchestration and real-time workflow management.

List of Companies Covered in this Report:

1. Accenture
2. Capgemini
3. Cognizant
4. Conduent
5. EXL Service Holdings
6. Firstsource Solutions
7. GeBBs Healthcare Solutions
8. Genpact
9. HCL Technologies
10. Hinduja Global Solutions (HGS)
11. IBM
12. IQVIA
13. Omega Healthcare
14. OutsourceRCM
15. Parexel International
16. R1 RCM
17. Sutherland Healthcare Solutions
18. Tata Consultancy Services (TCS)
19. United Health Group
20. Wipro

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Escalating Administrative-Cost Pressure on Payers & Providers
  • 4.2.2 Advanced Tech Adoption (AI, RPA, Analytics) Unlocking Scale Efficiencies
  • 4.2.3 Heightening Regulatory Complexity
  • 4.2.4 Surge In BPaaS Adoption by Small & Mid-Size Regional Payers
  • 4.2.5 Medicaid Redetermination Backlog Driving Eligibility-Processing Demand
  • 4.2.6 Generative-AI Prior-Auth & Coding Accelerating Revenue-Cycle Outsourcing
• 4.3 Market Restraints
  • 4.3.1 Cyber-Security & Data-Privacy Concerns Post High-Profile Breaches
  • 4.3.2 Shrinking Offshore Cost Arbitrage Amid Rising On-Shore Labor Costs
  • 4.3.3 U.S. Tariffs Inflating Imported It Hardware for Offshore Delivery Centers
  • 4.3.4 Vendor Consolidation Increasing Lock-In Risk for Mid-Tier Clients
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value - USD)

• 5.1 By Service Type
  • 5.1.1 Payer Service
    • 5.1.1.1 Human Resource Management
    • 5.1.1.2 Claims Management
    • 5.1.1.3 Customer Relationship Management (CRM)
    • 5.1.1.4 Operational / Administrative Management
    • 5.1.1.5 Care Management
    • 5.1.1.6 Provider Management
    • 5.1.1.7 Other Payer Services
  • 5.1.2 Provider Service
    • 5.1.2.1 Patient Enrollment & Strategic Planning
    • 5.1.2.2 Patient Care Service
    • 5.1.2.3 Revenue Cycle Management (RCM)
  • 5.1.3 Pharmaceutical Service
    • 5.1.3.1 Research & Development Support
    • 5.1.3.2 Manufacturing Support
    • 5.1.3.3 Non-clinical Services
      • 5.1.3.3.1 Supply Chain & Logistics
      • 5.1.3.3.2 Sales & Marketing Support
      • 5.1.3.3.3 Other Non-clinical Services
• 5.2 By Delivery Model
  • 5.2.1 Onshore Delivery
  • 5.2.2 Nearshore Delivery
  • 5.2.3 Offshore Delivery
• 5.3 By Service Delivery Mode
  • 5.3.1 Captive (In-house) Centers
  • 5.3.2 Third-Party Outsourcing
  • 5.3.3 Hybrid / Co-sourcing
• 5.4 By End Customer
  • 5.4.1 Healthcare Payers (Insurers & PBMs)
  • 5.4.2 Healthcare Providers (Hospitals, Physician Groups)
  • 5.4.3 Pharmaceutical & Biotech Companies
  • 5.4.4 Government Agencies

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Accenture PLC
  • 6.3.2 Capgemini
  • 6.3.3 Cognizant
  • 6.3.4 Conduent
  • 6.3.5 EXL Service Holdings
  • 6.3.6 Firstsource Solutions
  • 6.3.7 GeBBS Healthcare Solutions
  • 6.3.8 Genpact Limited
  • 6.3.9 HCL Technologies
  • 6.3.10 Hinduja Global Solutions (HGS)
  • 6.3.11 IBM Corporation
  • 6.3.12 IQVIA
  • 6.3.13 Omega Healthcare
  • 6.3.14 OutsourceRCM
  • 6.3.15 Parexel International
  • 6.3.16 R1 RCM
  • 6.3.17 Sutherland Healthcare Solutions
  • 6.3.18 Tata Consultancy Services (TCS)
  • 6.3.19 UnitedHealth Group
  • 6.3.20 Wipro

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment